Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dora B. Balogh"'
Autor:
Dora B. Balogh, Gernot Hudelist, Dmitrijs Bļizņuks, Jayanth Raghothama, Christian M. Becker, Roman Horace, Harald Krentel, Andrew W. Horne, Nicolas Bourdel, Gabriella Marki, Carla Tomassetti, Ulrik Bak Kirk, Nandor Acs, Attila Bokor
Publikováno v:
PLoS ONE, Vol 19, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/dfca6af5b09b4e00bd5d2e839c5397c2
Autor:
Judit Hodrea, Adar Saeed, Agnes Molnar, Attila Fintha, Adrienn Barczi, Laszlo J. Wagner, Attila J. Szabo, Andrea Fekete, Dora B. Balogh
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
Introduction Cardiovascular disease (CVD) is two to five times more prevalent in diabetic patients and is the leading cause of death. Therefore, identification of novel therapeutic strategies that reduce the risk of CVD is a research priority. Clinic
Externí odkaz:
https://doaj.org/article/b7f2028536634ea6b025f8a427402667
Autor:
Akos Roland Toth, Tamas Lakat, Judit Hodrea, Dora B Balogh, Adam Vannay, Laszlo Wagner, Attila Szabo, Andrea Fekete, Adam Hosszu
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Renal ischemia/reperfusion injury (IRI)-induced acute kidney injury is associated with high mortality and morbidity and effective therapies are lacking. We previously showed that Sigma-1 receptor (S1R) agonist fluvoxamine treatmen
Autor:
Judit Hodrea, Adar Saeed, Agnes Molnar, Attila Fintha, Adrienn Barczi, Laszlo J. Wagner, Attila J. Szabo, Andrea Fekete, Dora B. Balogh
Publikováno v:
PloS one. 17(2)
Introduction Cardiovascular disease (CVD) is two to five times more prevalent in diabetic patients and is the leading cause of death. Therefore, identification of novel therapeutic strategies that reduce the risk of CVD is a research priority. Clinic